BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 4)

AstraZeneca’s Evusheld monoclonal antibodies combo for pre-exposure prophylaxis receives EUA

By

NewsDesk  @infectiousdiseasenews On Wednesday, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld for the pre-exposure prophylaxis of COVID-19...

Lyme disease: Abandoned antibiotic, Hygromycin A, selectively kills B. burgdorferi in mice

By

NewsDesk  @infectiousdiseasenews Lyme disease cases are becoming more frequent and widespread. Currently, it affects almost half a million people nationwide each year. Lyme disease is caused by a bacterium, Borelliella...

Artesunate Amivas (artesunate) granted approval in Europe for treatment of severe malaria

By

By NewsDesk  @bactiman63  AMIVAS Ireland Ltd., specialists in treatments for rare and neglected tropical diseases, including severe malaria, announced today the European Commission has granted approval...

CMV: FDA approves Livtencity for treating post-transplant infections

By

The U.S. Food and Drug Administration approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients (12 years of age and older and weighing at least 35 kilograms) with post-transplant...

Ukraine: 4 out of 10 people purchased drugs whose effectiveness and safety have not been proven

By

By NewsDesk  @bactiman63  An analysis by the Center for Combating Corruption conclude in a new study that 4 out of 10 people purchased drugs that are ineffective and absent in modern treatment standards....

COVID-19

Monoclonal antibody treatment highly effective at reducing COVID-19 hospitalizations

By

By NewsDesk  @bactiman63 Researchers this week published interim results in The New England Journal of Medicine from a Phase 3 study of the COVID-19 monoclonal antibody treatment sotrovimab, sponsored...

Antibiotics: Cubicin recalled due to presence of glass particles

By

NewsDesk @bactiman63 Merck announced voluntarily recalling one lot of CUBICIN® (daptomycin for injection) 500mg for intravenous use, Lot 934778, Exp June 2022. Because treatment with CUBICIN is likely...

Herpes Treatment: Taiwanese and Chinese companies team up to work on long-acting UB-621

By

By NewsDesk  @bactiman63 United BioPharma announced this week that Shanghai Public Health Clinical Centre and Cheng Kung University’s Department of Microbiology and Immunology have joined United...

FDA Approves Expanded Pediatric Indication for HIV Treatment Regimen

By

By NewsDesk  @bactiman63 Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved a new low-dose tablet dosage form of Biktarvy® (bictegravir 30 mg/emtricitabine 120...

COVID-19

Merck plans to submit for EUA for COVID-19 pill, molnupiravir

By

Merck and Ridgeback Biotherapeutics announced recently that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine, significantly reduced the risk of hospitalization or death at...